These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29319159)

  • 1. Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium.
    Mulugeta LY; Yao L; Mould D; Jacobs B; Florian J; Smith B; Sinha V; Barrett JS
    Clin Pharmacol Ther; 2018 Jul; 104(1):81-87. PubMed ID: 29319159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking Down Barriers to Effective Patient Care.
    O'Donnell PH; Reynolds KS
    Clin Pharmacol Ther; 2018 Mar; 103(3):360-364. PubMed ID: 29417567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends.
    Liu Q; Ahadpour M; Rocca M; Huang SM
    AAPS J; 2021 Apr; 23(3):54. PubMed ID: 33846878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big Data in the Assessment of Pediatric Medication Safety.
    McMahon AW; Cooper WO; Brown JS; Carleton B; Doshi-Velez F; Kohane I; Goldman JL; Hoffman MA; Kamaleswaran R; Sakiyama M; Sekine S; Sturkenboom MCJM; Turner MA; Califf RM
    Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31937606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the "Blip on the Radar Screen": Leveraging Big Data in Defining Drug Safety and Efficacy in Pediatric Practice.
    Christensen ML; Davis RL
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S86-S93. PubMed ID: 30248191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where Will Statistical Sciences for Clinical Pharmacology Be in 2030?
    Smith BP
    Clin Pharmacol Ther; 2020 Jan; 107(1):17-21. PubMed ID: 31863686
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement of the American College of Clinical Pharmacology on Drug Regulation Reform Act.
    Ahlquist RP
    J Clin Pharmacol; 1979; 19(2-3):165-6. PubMed ID: 422741
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric Drug Development: Outlook for Science-Based Innovation.
    Green DJ; Zineh I; Burckart GJ
    Clin Pharmacol Ther; 2018 Mar; 103(3):376-378. PubMed ID: 29384202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value and future of clinical pharmacology.
    Honig P
    Clin Pharmacol Ther; 2007 Jan; 81(1):17-8. PubMed ID: 17185990
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Development 101: A Primer.
    Buckley LA; Bebenek I; Cornwell PD; Hodowanec A; Jensen EC; Murphy C; Ghantous HN
    Int J Toxicol; 2020; 39(5):379-396. PubMed ID: 32762387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care.
    Swift B; Jain L; White C; Chandrasekaran V; Bhandari A; Hughes DA; Jadhav PR
    Clin Transl Sci; 2018 Sep; 11(5):450-460. PubMed ID: 29768712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse.
    Shebley M; Menon RM; Gibbs JP; Dave N; Kim SY; Marroum PJ
    J Clin Pharmacol; 2019 May; 59(5):625-637. PubMed ID: 30562405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel trial design: a report from the 19th frontiers symposium of ACCP.
    Ameer B
    J Clin Pharmacol; 2008 Jul; 48(7):793-8. PubMed ID: 18499884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minipig as nonrodent species in toxicology--where are we now?
    Ganderup NC; Harvey W; Mortensen JT; Harrouk W
    Int J Toxicol; 2012; 31(6):507-28. PubMed ID: 23134714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists. 12th Annual Meeting, 4-6 December 1978, Monash University, Clayton, Victoria.
    Clin Exp Pharmacol Physiol; 1979; 6(6):637-711. PubMed ID: 42500
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMERICAN Society for Pharmacology and Experimental Therapeutics, Forty-first Annual Meeting, Cleveland, Ohio, April 29-May 3, 1951.
    Fed Proc; 1951 Mar; 10(1:2):479-94. PubMed ID: 14823044
    [No Abstract]   [Full Text] [Related]  

  • 18. AMERICAN Society for Pharmacology and Experimental Therapeutics, Forty-first Annual Meeting, Cleveland, Ohio, April 29-May 3, 1951.
    Fed Proc; 1951 Mar; 10(1:1):275-348. PubMed ID: 14823038
    [No Abstract]   [Full Text] [Related]  

  • 19. Exodus of clinical pharmacologists and pharmacometricians from academia--Who is to blame? A policy statement from the American College of Clinical Pharmacology.
    Upreti VV;
    J Clin Pharmacol; 2015 Sep; 55(9):955-6. PubMed ID: 25975569
    [No Abstract]   [Full Text] [Related]  

  • 20. The Need for Pediatric Drug Development.
    Ward RM; Benjamin DK; Davis JM; Gorman RL; Kauffman R; Kearns GL; Murphy MD; Sherwin CMT
    J Pediatr; 2018 Jan; 192():13-21. PubMed ID: 28942898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.